Accéder au contenu
Merck
Toutes les photos(1)

Documents

C-111

Supelco

Catecholamine Metabolites Mix solution

1 mg/mL each component in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C9H10O5
Poids moléculaire :
198.17
Numéro CE :
200-659-6
Code UNSPSC :
41116107
Nomenclature NACRES :
NA.24

Qualité

certified reference material

Niveau de qualité

300

Forme

liquid

Caractéristiques

SNAP-N-SPIKE®/SNAP-N-SHOOT®

Composition

Homovanillic acid
5-Hydroxyindole-3-acetic acid
(±)-Vanilmandelic acid

Conditionnement

ampule of 1 mL

Fabricant/nom de marque

Cerilliant®

Concentration

1 mg/mL each component in methanol

Technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

Application(s)

clinical testing
forensics and toxicology

Format

multi-component solution

Température de stockage

−70°C

Description générale

A Certified Spiking Solution® of major catecholamine metabolites 5-Hydroxyindole-3-acetic acid (5-HIAA), Homovanillic acid (HVA), and (±)-Vanilmandelic acid (VMA). This multi-component mix is suitable for use in preparation of linearity standards, calibrators, or controls as well as for other critical quantitative applications such as internal proficiency testing or for OEM use in preparation of reagents, assay development, and instrument IQ/OQ. Certified concentration values for each component provides increased efficiency from less time remaking pools due to dilution errors or rerunning samples.
.

Informations légales

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Analyte

Description
    DL-4-Hydroxy-3-methoxymandelic acid
    5-Hydroxyindole-3-acetic acid
    Homovanillic acid

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

C-109

Catecholamine Mix 1 (Epinephrines) solution, 1.0 mg/mL each component in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

C-110

Catecholamine Mix 2 (Metanephrines) solution, 1.0 mg/mL each component in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

D-072

Dopamine-D4 hydrochloride solution, 100 μg/mL in methanol with 5% 1 M HCl (as free base), ampule of 1 mL, certified reference material, Cerilliant®

D-081

Dopamine hydrochloride solution, 1.0 mg/mL in methanol with 5% 1 M HCl (as free base), ampule of 1 mL, certified reference material, Cerilliant®

E-077

(±)-Epinephrine-D6 solution, 100 μg/mL in methanol with 5% 1 M HCl, ampule of 1 mL, certified reference material, Cerilliant®

H-091

(+\-)-4-Hydroxy-3-methoxymandelic Acid-D3 (ring-D3) solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-092

4-Hydroxy-3-methoxyphenyl-D3-acetic-D2 Acid solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

M-148

(±)-Metanephrine-D3 hydrochloride solution, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-068

(±)-Normetanephrine-D3 hydrochloride solution, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-069

(±)-Norepinephrine-D6 hydrochloride solution, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

Pictogrammes

FlameSkull and crossbonesHealth hazard
GHS02,GHS06,GHS08

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Organes cibles

Eyes

Code de la classe de stockage

3 - Flammable liquids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

49.5 °F - closed cup

Point d'éclair (°C)

9.7 °C - closed cup

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Sravanth K Hindupur et al.
Nature, 555(7698), 678-682 (2018-03-22)
Histidine phosphorylation, the so-called hidden phosphoproteome, is a poorly characterized post-translational modification of proteins. Here we describe a role of histidine phosphorylation in tumorigenesis. Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and
Verena Albert et al.
EMBO molecular medicine, 8(3), 232-246 (2016-01-17)
Activation of non-shivering thermogenesis (NST) in brown adipose tissue (BAT) has been proposed as an anti-obesity treatment. Moreover, cold-induced glucose uptake could normalize blood glucose levels in insulin-resistant patients. It is therefore important to identify novel regulators of NST and
Daniel K Newhard et al.
Journal of veterinary internal medicine, 32(5), 1555-1563 (2018-08-08)
The effects of sacubitril/valsartan (S/V) on the renin-angiotensin-aldosterone system (RAAS) in dogs with cardiomegaly secondary to myxomatous mitral valve disease (MMVD) are currently unknown. To determine the pharmacodynamic effects of S/V on the RAAS, natriuretic peptide concentrations, systolic arterial pressure
Z K Saritas et al.
Bratislavske lekarske listy, 115(8), 508-513 (2014-09-24)
The study included 12 clinically healthy, adult male dogs of various breeds, admitted to our clinic for castration. After general anesthesia with sevoflurane, we administered epidural fentanyl (1 mcg/kg) to fentanyl group, while lidocaine group was given Lidocaine (3 mg/kg)
Janaína Garcia Gonçalves et al.
PloS one, 9(9), e107228-e107228 (2014-09-16)
Despite a significant improvement in the management of chronic kidney disease (CKD), its incidence and prevalence has been increasing over the years. Progressive renal fibrosis is present in CKD and involves the participation of several cytokines, including Transforming growth factor-β1
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique